Why pay more?!!Why pay .35 for a share of tlt when the up coming P/P sale will be considerably less ?
Sure these poor current share holders are stuck with what they have and so resort to denial of what this dilutions means. This question is more for people who own no shares and are considering jumping in without hesitation.
The dilution will be greater than 50%
The clinical studies will cost well over $30 million.
After 12 years in operation this company has ZERO cash reserves!!! I’m sorry, if this is not a red flag then close your eyes and dive right in.
They hope to finally complete phase 2 in another 3 years. Usually there is a 3rd phase requirement.
By this time another big pharma company could possibly have a better treatment available. And the big boys don’t procrastinate and they don’t do business on a shoe string budget.
Check out some of the interesting treatments other companies, with money, are perusing.